">
Back to Landing

About

Built to last.

YOURTIMEONEARTH is an independent IP development company operating at the intersection of computational genomics and climate science. We develop proprietary mathematical methods, validate them against scientific standards, and license the resulting infrastructure to industry.

The genomic offset predictor is our first commercial implementation. It is patent pending, scientifically validated, and operational. It replaces months of empirical testing with milliseconds of computation — without sacrificing accuracy or interpretability.

We are not a consulting firm. We are not a service provider. We do not take investment. We build methods, protect them, and license them. The agricultural platform is proof of concept for a broader programme that will expand into additional verticals over time.

Every decision made here is oriented toward one outcome: building durable, protected, compounding value from mathematical methods that solve real problems faster and cheaper than the incumbents thought possible.

Founding Statement
Independent. Patent Pending. Operational.
First vertical: climate-adaptive agriculture.
Patent Pending Operational IP Licensing Model Computational Genomics Climate · Agriculture
IP
Independent
Development
8/8
Validation
Tests Passed
Patent
Pending
Operationally
Deployed

How we operate

Principle 01
Validate first
Nothing is deployed without passing independent scientific validation. The genomic offset predictor passed eight tests covering home-environment suitability, cross-environment avoidance, gradient monotonicity, and confidence calibration. This standard applies to every future method.
Principle 02
Protect before deploying
IP is filed before the first licence conversation. The value of a method is destroyed if it is disclosed without protection. Every implementation is documented, attributed, and filed. Every licence agreement is structured around the protected asset.
Principle 03
License, not service
We do not offer bespoke consultancy or custom development for hire. We license methods. This distinction is structural: services require people, licences require protection. The model scales without proportional cost. Each additional licensee increases revenue without increasing overhead.

Intellectual Property

Patent pending.
Every method protected.

IP is filed before the first licence conversation. The RDA-based genomic offset predictor is the subject of a pending patent application covering the core mathematical method, the real-time inference architecture, and the multi-tenant enterprise delivery model.

Status
Patent Pending
Priority date established. Disclosure protected. Application in examination.
Coverage
Method + Platform
Core RDA mathematics, real-time inference engine, and multi-tenant API covered as one unified invention.
Licence Model
Exclusive · Non-Exclusive
Territory and use-case based licensing available. Exclusive rights negotiable for defined sectors or geographies.
Readiness
Operational · Now
Trained, deployed, processing predictions. No integration lag. Licences executable within weeks.

Architecture

No dependency on external
AI providers.

The genomic offset method is implemented entirely from first principles using Redundancy Analysis — a deterministic, auditable, peer-reviewed multivariate technique. Predictions are explainable, reproducible, and auditable — a critical requirement where breeding liability matters.

FastAPI + Python 3.11+
Async, type-safe, OpenAPI auto-docs
NumPy / SciPy RDA kernel
Eigenvalue decomposition, 0.015ms per call
SQLite + JWT multi-tenant auth
Role-based, audit-logged, offline-capable
Zero cloud / AI / subscription dependencies
Fully self-hosted, no API keys required

Ready to explore a partnership?

Contact Us →